Facebook
Twitter
LinkedIn
ForwardPULSE: To DOAC or Not: Treatment of VTE in Patients with Morbid Obesity
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Target Audience
Pharmacist
Learning Objectives
1. Discuss the differences of pharmacokinetics in non-obese and obese populations
2. Describe current guideline recommendations and available literature for the use of DOACs vs. other anticoagulants options in morbidly obese populations
3. Identify an acceptable anticoagulation plan for VTE treatment in a patient with morbid obesity
Additional Information
| Attachment | Size |
|---|---|
 Handout.pdf | 169.74 KB |
 Pulse May 11th.docx | 14.32 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Heting Zhang, PharmD, MBA
PGY1 Pharmacy Resident
UPMC Presbyterian
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.